![](https://investorshub.advfn.com/uicon/464250.png?cb=1565891104)
Sunday, June 23, 2019 12:54:39 PM
Now Dr. Bosch and the rest of NWBO are emphasizing not conducting an efficacy data lock until the SAP is etched in stone.
1) I do not recall "the rest of NWBO" emphasizing that an efficacy data lock will not be conducted until SAP is etched in stone.
2) I thought that Dr Bosch was indicating that the SAP had to be etched in stone prior to "hard lock" & topline.
Which might not preclude that a "soft lock" has already taken place?
I have the impression that one needs to do a soft lock, and then conduct an audit of the data (including completion of all the queries).
I also have the impression that once NWBO has "finalized" the SAPs (after submitting the draft SAPs and after some back and forth with RAs to make sure that they are on board with the concept of the revised SAP), then the final data lock would be expected shortly thereafter. And then the data analysis, based on the final SAPs, will start to take place soon too.
I think there will typically be a reasonable amount of time between soft lock and hard lock .... so I imagine that the soft lock would take place perhaps a minimum of 6 months prior to completion of the draft & final SAP?
www.ijrpc.com/files/25-10-16/28-6122.pdf includes:
The success of any clinical trial is dependent on assuring that the data collected is of good quality. Clinical Data Management is the process of collection, cleaning, and management of subject data in compliance with regulatory standards. It is a critical phase in clinical research, which leads to generation of high-quality, reliable, and statistically sound data from clinical trials. Audit forms an important part of a quality system to assure the data generated is of high-quality, reliable, and statistically sound and to provide verification of data integrity. Clinical data base audits may be conducted at any facility or institution where clinical trials are conducted on human volunteers or subjects. Auditors should be selected based on the suitable qualifications, experience and training. Adherence to specific audit principles is a prerequisite for providing a reliable and relevant audit outcome. Like in all other audits, database audits require careful preparation. Audits of the database are conducted between ‘soft lock’ and ‘hard lock’ (’freeze’ and ‘lock’) of the database. Data transcribed from a Case Report Form or other source into the database is usually checked for accuracy through a database audit.
data base audit program will point out potential problem areas early, so solutions can be found before the data submission to regulatory authorities.
audit = a systematic and independent examination of trial related activities and documents to determine whether the evaluated trial related activities were conducted, and the data were recorded, analysed and accurately reported according to the protocol, sponsor‘s standard operating procedures (SOPs), Good Clinical Practice (GCP), and applicable regulatory requirement(s).
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM